Compare LXP & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXP | TWST |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | N/A | 2018 |
| Metric | LXP | TWST |
|---|---|---|
| Price | $46.54 | $47.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $51.88 | $48.75 |
| AVG Volume (30 Days) | 526.2K | ★ 903.2K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.99% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $1.02 | $18.91 |
| Revenue Next Year | $7.42 | $15.07 |
| P/E Ratio | $26.35 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $6.85 | $23.30 |
| 52 Week High | $52.52 | $57.88 |
| Indicator | LXP | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 52.43 |
| Support Level | $8.52 | $41.69 |
| Resistance Level | $51.06 | $57.88 |
| Average True Range (ATR) | 1.14 | 2.73 |
| MACD | -0.12 | 0.12 |
| Stochastic Oscillator | 34.96 | 61.29 |
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.